Fingerprint
Dive into the research topics of 'The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: An analysis of the 29 case reports'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: An analysis of the 29 case reports
Research output: Contribution to journal › Article › peer-review
67
Scopus
citations